Production (Stage)
Cytophage Technologies Ltd.
CYTO.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -87.70% | 3,102.70% | -- | -- | 148.26% |
| Total Receivables | -76.47% | -45.57% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -25.47% | 290.20% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -70.43% | -97.96% | -- | -- | -- |
| Total Current Assets | -86.14% | -43.29% | -- | -- | -- |
|
|
|||||
| Total Current Assets | -86.14% | -43.29% | -- | -- | -- |
| Net Property, Plant & Equipment | 7.97% | 14.75% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -59.27% | -16.74% | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | 10.26% | -46.99% | -- | -- | -- |
| Total Accrued Expenses | -23.80% | -41.81% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -35.10% | -43.34% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -17.39% | -82.78% | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | -17.39% | -82.78% | -- | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.28% | -14.82% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -15.46% | -63.67% | -- | -- | -- |
|
|
|||||
| Common Stock & APIC | -5.34% | 43.43% | -- | -- | -- |
| Retained Earnings | -11.74% | -27.71% | -- | -- | -- |
| Treasury Stock & Other | -15.88% | 17.69% | -- | -- | -- |
| Total Common Equity | -74.35% | 621.64% | -- | -- | 88.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -74.35% | 621.64% | -- | -- | 88.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -74.35% | 621.64% | -- | -- | 88.32% |
|
|
|||||